Products

Albumin

• Human Albumin 20% Behring, low salt | Human Albumin 20%

  Indications:

  – Increase in oncotic pressure in case of oncotic deficiency.

  – Diluted as a 4 – 5% solution for iso-oncotic volume replacement with long-term effect.

  – Therapy of albumin deficiency.

• AlbuRx® | Human Albumin 25%

  Indications:

  Restoration and maintenance of circulating blood volume in cases of volume deficiency where the use of a colloid is indicated.

  The choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

• Albuminar® | Human Albumin 25%

  Indication:
  SHOCK – Albumin is indicated in the emergency treatment of shock and in other similar conditions where the restoration of blood volume is urgent. If there has been considerable loss of red blood cells, transfusion with packed red blood cells is indicated.
  BURNS – Albumin or Albumin in either normal saline or dextrose is indicated to prevent marked hemoconcentration and to maintain appropriate electrolyte balance.
  HYPOPROTEINEMIA with or without edema – Albumin is indicated in those clinical situations usually associated with a low concentration of plasma protein and a resulting decreased circulating blood volume. Although diuresis may occur soon after albumin administration has been instituted, best results are obtained if albumin is continued until the normal serum protein level is regained.

Human normal Immunoglobulin

• Hizentra®| Human normal immunoglobulin Subcutaneous 20% Liquid

  Indication:

  Replacement therapy in adults and children in primary immunodeficiency syndromes such as:

  – congenital agammaglobulinaemia and hypogammaglobulinaemia

  – common variable immunodeficiency- severe combined immunodeficiency and Wiskott-Aldrich syndrome

  – IgG subclass deficiencies with recurrent infections

  Replacement therapy in myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. Immunomodulatory therapy:

  – treatment of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) as maintenance therapy to prevent relapse of neuromuscular disability and impairment.

• Privigen® | Human normal immunoglobulin Intravenous, 10% Liquid

  Indication:

  Replacement therapy in:

  • Primary immunodeficiency syndromes (PID) such as:

  – congenital agammaglobulinaemia and hypogammaglobulinaemia

  – common variable immunodeficiency

  – severe combined immunodeficiency

  – severe combined immunodeficiency – Wiskott-Aldrich syndrome

  • Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections

  • Children with congenital AIDS and recurrent infections

  • Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).

  Immunomodulation in adult, and children and adolescents (0-18 year old) in:

  • Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count

  • Guillain-Barré syndrome

  • Kawasaki disease

  • Kawasaki disease • Chronic inflammatory demyelinating polyneuropathy (CIDP)

Medical device

• FREEDOM60®

  Introduction:

  The FREEDOM60® Syringe Infusion System is portable and easy to use requiring no batteries or electric. There are only two operating knobs and special precision tubing sets are used to control the flow rate.

  The FREEDOM60® operates at a constant safe pressure. The constant pressure developed in the FREEDOM60® automatically decreases the flow rate if there is an increase in resistance during the delivery. The system will find equilibrium between the increasing resistance and flow rate. It provides constant flow which tends to inhibit clots, and holds full pressure after an infusion is complete to prevent blood or drug backflow. The FREEDOM60® also eliminates concerns of a bolus, overflow, overdose or runaway infusion.

  For SCIg, the advantage of dynamic equilibrium is the system’s ability to decrease the ow for any pressure increases caused by tissue saturation, or improper needle placement (e.g., over a muscle, in scar tissue, needle not deep enough, needles too close together). Indications for Use:

  The FREEDOM60® Syringe Infusion System is indicated for intravenous, intra-arterial, enteral, subcutaneous and epidural infusion of medications or uids requiring continuous delivery at controlled infusion rates. The FREEDOM60® is also intended to provide continuous infusion of a local anesthetic directly into the intraoperative site for postoperative pain management.

• HIgH-Flo Subcutaneous Safety Needle Sets™

  Indication:

  Subcutaneous Safety Needle Set: High-Flo
  Indications for use: Subcutaneous Needle Sets are intended for the subcutaneous infusion of
  prescribed liquid medicines from an external infusion pump or syringe.

• Flow Rate Tubing™

  Precision Flow Rate Tubing™ controls the infusion rate of the Freedom syringe infusion systems. When combined with the viscosity of the medication and safe pressure of the Freedom infusion systems, Precision Flow Rate Tubing™ provides an accurate delivery that responds in real time to a patient’s needs.
  Instructions:
  1. Connect the luer disc end of the tubing set to the syringe.
  2. Connect the male end of the tubing set to the indwelling catheter (IV) or needle set (Sub-q).
  3. When inserting the syringe into the pump, make sure the tubing luer disc is fully seated in the pump’s nose.